Families to the fore in healthcare
The healthcare sector is dominated by family-run firms, some of which have come into prominence in the past year.
pharmaceuticals
May 2021
April 2021
March 2021
February 2021
January 2021
November 2020
April 2020
February 2020
The Ellas of Bharat Biotech: The gift of the jab
Bharat Biotech, founded by Krishna Ella and his wife Suchitra, has been at the forefront of making vaccines for a while. Yet it took a global pandemic for the spotlight to shine on the company.
Reimagining Indian pharma
India’s pharma industry is reimagining itself. This is not just borne out of the necessities brought forth by the pandemic, but is a blueprint to thrive and to succeed in this new world.
This decade will mirror the ’90s: Kenneth Andrade
The veteran of the investment industry argues that this decade will witness an export-led growth. And while IT and pharma would rule the economy, other smaller industries, too, will jostle to rise up.
Why transformation is a buzzword at Piramal
Billionaire industrialist Ajay Piramal is in makeover mode. He wants to remould his conglomerate into a well-diversified NBFC and a pharma firm, which would both be giants in their respective spaces.
Budget 2021’s focus on healthcare has industry elated
After a long time, the Union Budget has brought back a renewed focus on healthcare and health infrastructure, which it aims to achieve through a slew of measures. The health industry is elated.
How safe is the Covid-19 vaccine?
As we look ahead to immunisation in 2021, there is the fear of adverse reactions to the drugs as the vaccines have been tested for less than six months. But a framework exists to deal with such cases.
Healthcare leaders shine in MPW 2020 list
Cipla’s Samina Hamied, Lupin’s Vinita Gupta biggest rank gainers from the sector.
Bears take a break
Benchmark indices record their biggest single-day gain since May 2009.
Cipla: Breath of new air
Structural changes in the global pharma industry are throwing up challenges and opportunities. Enter Cipla with its expertise in medicine, and vision for relevance beyond pharma.
